FindTrial
Sign In

Development and application of early diagnostic markers for myocardial fibrosis

Development and application of early diagnostic markers for myocardial fibrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064672
Enrollment
Unknown
Registered
2022-10-14
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial fibrosis

Interventions

Myocardial fibrosis:NA
Healthy group:NA

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age > 18 years; 2. Patients have complete clinical information; 3. Myocardial fibrosis was confirmed by cardiologist after cardiac magnetic resonance imaging or echocardiography.

Exclusion criteria

Exclusion criteria: 1. Other malignant diseases in the past or during treatment; 2. Pregnant or lactating women; 3. Weight loss >10% in the previous three months; 4. Drug addiction, chronic alcoholism and AIDS patients; 5. Uncontrollable seizures or loss of self-control due to mental illness; 6. Those who are considered unfit to participate in this study.

Design outcomes

Primary

MeasureTime frame
GDF-15;Gal-3;—

Countries

China

Contacts

Public ContactChuanbao Li

Beijing Hospital

lcb9731@163.com+86 13810424406

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026